Journals / Archives of epilepsy (Online) / 2022 / Cilt: 28 - Sayı: 2

Effect of Resveratrol on a Penicillin-Induced Epilepsy Model in Rats

Pages
78–84
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this rat experimental epilepsy model created with penicillin, administration of resveratrol alone did not create a statistically significant difference in epileptiform activity; however, administration of resveratrol with sodium valproate significantly decreased epileptiform activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Epilepsy, one of the most common chronic neurological diseases, is characterized by spontaneous recurrent seizures.
📊
Key Findings & Data:Methods: A total of 40 Wistar albino rats were divided into 5 groups of 8.
💡
Conclusion & Impact:Conclusion: In this rat experimental epilepsy model created with penicillin, administration of resveratrol alone did not create a statistically significant difference in epileptiform activity; however, administration of resveratrol with sodium valproate significantly decreased epileptiform activity.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Epilepsy, one of the most common chronic neurological diseases, is characterized by spontaneous recurrent seizures. Many studies, using various experimental epilepsy models, have shown that resveratrol reduces epileptiform activity and has neuroprotective effects. Using an epilepsy model created with penicillin, we aimed to investigate the effect of resveratrol on epileptiform activity in rats. Methods: A total of 40 Wistar albino rats were divided into 5 groups of 8. In the control group, only 2.5 µL of saline was administered intracranially (ic). In the penicillin group, 500 IU of penicillin was given intracranially with no additional procedure. In the resveratrol group, 40 mg/kg of resveratrol was administered intraperitoneally (ip) 20 minutes after penicillin was given intracranially. In the sodium valproate group, 20 minutes after penicillin ic, 300 mg/kg of sodium valproate was administered intraperitoneally. In the resveratrol+sodium valproate group, 20 minutes after penicillin ic, 40 mg/kg of resveratrol was administered intraperitoneally to the right side and 300 mg/kg of sodium valproate ip to the left side. The rats were placed in a stereotaxic device after the procedure and electrocorticogram recordings were captured for 180 minutes. Results: The number of spikes and the average amplitude of the spikes (peak-to-peak) were calculated from the electrophysiological recording data. In the resveratrol group, there was no statistically significant difference in spike frequency and amplitude values. In the resveratrol+sodium valproate group, the spike frequency values decreased significantly from the 30th minutes (P = .028 < .05) and the amplitude decreased significantly from the 60th minutes (P = .018 < .05). Conclusion: In this rat experimental epilepsy model created with penicillin, administration of resveratrol alone did not create a statistically significant difference in epileptiform activity; however, administration of resveratrol with sodium valproate significantly decreased epileptiform activity.

🔖

Cite This Article

NACAR, T., ACUNGİL, Z. K. (2022). Effect of Resveratrol on a Penicillin-Induced Epilepsy Model in Rats. Archives of epilepsy (Online), Cilt: 28 - Sayı: 2, 78–84. https://ajindex.com/articles/447845

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Punnakkal P, Dominic D. NMDA receptor GluN2 subtypes control epileptiform events in the hippocampus. NeuroMolecular Med. 2018
  2. 20(1):90-96. [CrossRef] 2. Brennan GP, Henshall DC. microRNAs in the pathophysiology of epilepsy. Neurosci Lett. 2018
  3. [CrossRef] 3. Brigo F, Igwe SC, Del Felice A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev. 2016
  4. 2016(8):1-29. [CrossRef] 4. Li J, Xing H, Jiang G, et al. Increased expression of Rac1 in epilepsy patients and animal models. Neurochem Res. 2016
  5. 41(4):836-843. [CrossRef] 5. Lukasiuk K. Encyclopedia of the neurological sciences. In: Daroff R., Aminoff M, eds. Epileptogenesis. 2nd ed. USA: Academic Press of Elseiver
  6. Mumcuoglu İ, Kurt S, Aydın D, et al. Effect of varying doses of intraveneous paracetamol on the electrical activity of the brain in penicillin-induced status epilepticus in rats. J Turk Epilepsi Soc. 2015
  7. 21(1):13-19. 7. Pitkänen A, Lukasiuk K, Dudek FE, Staley KJ. Epleptogenesis. Cold Spring Harb Perspect Med. 2015
  8. 5(10):1-17. 8. Akdogan I, Goksin N. Experimental epilepsy models and morphologic alterations of experimental epilepsy models in brain and hippocampus. In: Kaneez F.S., ed. Underlying Mechanisms of Epilepsy. 1st ed. London: InTechOpen Lim
  9. Unal N, Akdogan I, Adiguzel E, Ozdemir B, Tufan AC. Effect of penicillininduced epilepsy seizure on the volume of hippocampus stratum pyramidalis in rat. Neurosci Res Commun. 2003
  10. 33(3):210-217. [CrossRef] 10. Marangoz C. Experimental models of epilepsy. J Exp Clim Med. 1997
  11. 14(3):147-186. 11. Arık AE, Bağırıcı F, Sefil F, Marangoz C. Effect of levetiracetam on penicillin induced epileptic activity in rats. Acta Neurobiol Exp (Wars). 2014
  12. 74(3):266-275. 12. Cloix JF, Hévor T. Epilepsy, regulation of brain energy metabolism and neurotransmission. Curr Med Chem. 2009
  13. 16(7):841-853. [CrossRef] 13. Löscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002
  14. 16(10):669- 694. [CrossRef] 14. Terbach N, Williams RSB. Structure-function studies for the panacea, valproic acid. Biochem Soc Trans. 2009
  15. 37(5):1126-1132. [CrossRef] 15. Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol. 2009
  16. 2(1):95-109. [CrossRef] 16. Castro OW, Upadhya D, Kodali M, Shetty AK. Resveratrol for easing status epilepticus induced brain injury, inflammation, epileptoge